Stephan MATHAS | Charité Universitätsmedizin Berlin, Berlin | Charité | Medical Department, Division of Hematology, Oncology and Tumor Immunology
TP53 mutation and survival in aggressive B cell lymphoma - Zenz - 2017 - International Journal of Cancer - Wiley Online Library
TP53 mutation and survival in aggressive B cell lymphoma - Zenz - 2017 - International Journal of Cancer - Wiley Online Library
Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP | Haematologica
Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH) | Leukemia
Gene expression profiling defines molecular subtypes of classical Hodgkin's disease | Oncogene
PDF) Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma | NEJM
Hodgkin lymphoma: 2016 update on diagnosis, risk‐stratification, and management - Ansell - 2016 - American Journal of Hematology - Wiley Online Library
Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B) | SpringerLink
51287 PDFs and publications in HODGKIN'S LYMPHOMA
CQSE: Our Team
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma | NEJM
Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B) | SpringerLink
PDF) Macrophages predict treatment outcome in Hodgkin's lymphoma
MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma - Sánchez‐Espiridión - 2013 - British Journal of Haematology - Wiley Online Library
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma | NEJM
Horst HUMMEL | University of Wuerzburg, Würzburg | JMU | Department of Internal Medicine II
PDF) Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival | Martin Dyer - Academia.edu
PDF) Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphoma
Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP | Haematologica
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma | NEJM
CQSE: Our Team
Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP | Haematologica
Gunther GLEHR | Universität Regensburg, Regensburg | UR | Department of Statistical Bioinformatics
